| Patent Number |
Title Of Patent |
Date Issued |
| 5750111 |
Mild newcastle disease virus vaccine |
May 12, 1998 |
| The present invention provides the novel Newcastle disease virus strain C2 which is able to induce a solid immune response in poultry without adverse vaccination reactions. |
| 5749976 |
Cleaning solution for automated analyzers |
May 12, 1998 |
| The invention relates to a novel cleaning solution for use particularly with automated analyzers used in clinical laboratories and a method of cleaning a surface with the cleaning solution. The solution eliminates problems of cross-contamination of samples due to reagent carryover which |
| 5744570 |
Copolyether amide and water vapour permeable film made therefrom |
April 28, 1998 |
| Claimed is a copolyether amide having a melting point in the range of 180.degree. to 260.degree. C., incorporating at least 10 wt. % and not more than 30 wt. % of ethylene oxide groups, and composed of 30 to 60 wt. % of polyamide segments and 70 to 40 wt. % of segments derived from a |
| 5743775 |
Laminate for restraining organic vapors, aerosols, and biological agents |
April 28, 1998 |
| A laminate that restrains organic vapors, aerosols, and biological agents, where at least one layer is implemented as a barrier layer, wherein the barrier layer is implemented from cellulose-based polymers over its entire surface and the laminate is water-vapor permeable, as well as to t |
| 5741897 |
Process for preparing an N-substitued aldonamide |
April 21, 1998 |
| The present invention generally relates to a process for preparing an N-substituted aldonamide by reacting an aldonic acid in a polar organic solvent with an amine of the formula HNR.sup.1 (X--NR.sup.1)nR.sup.2, wherein R1 and R.about. may be the same or different and represent a hyd |
| 5741787 |
Antiglucocorticoid steroids for the treatment of anxiety disorders |
April 21, 1998 |
| The invention relates to the use of antiglucocorticoid steroids for the manufacture of a pharmaceutical composition for the treatment of anxiety disorders. |
| 5741786 |
Steroids with a 17-spiromethylene lactone or lactol group |
April 21, 1998 |
| A steroid with a 17-spiromethylene lactone group having formula I ##STR1## wherein R.sub.1 is O, (H,H), (H,OR), or NOR, R being selected from H, (1-6C) alkyl and (1-6C) acyl; R.sub.2 is H, (1-6C) alkyl optionally substituted by a halogen, (2-6C) alkenyl optionally substituted by a |
| 5739363 |
Isomerisation of equilin |
April 14, 1998 |
| The invention relates to a method of isomerisation of equilin or a derivative thereof to delta(8,9)-dehydro estrone [delta(8,9)DHE], characterized in that equilin or a derivative thereof is treated with a lithium salt of ethylenediamine or with lithium amide in dimethylsulfoxide. |
| 5738854 |
Pseudorabies virus vaccine |
April 14, 1998 |
| The present invention is concerned with the preparation of a pseudorabies virus (PRV) mutant, formed by a mutation in open reading frame 1 of the BamHI fragment 4. The invention also relates to a PRV mutant containing a heterologous gone encoding an antigen of a porcine pathogan, which i |
| 5738791 |
Extraction of metal ions from an aqueous solution |
April 14, 1998 |
| A method for the making and use of a porous, preferably dimensionally stable, hydrophobic polymer for the extraction of metal ions from an aqueous solution, with the polymer being in the form of a regenerative granulate or powder having an average particle diameter of from 0.1 to 10 |
| 5736507 |
Peptides derived from autoantigen for use in immunotherapy of autoimmue diseases |
April 7, 1998 |
| The present invention relates to novel peptides derived from the autoantigen HC gp-39, said peptides comprising at least one of the amino acid sequences FGRSFTLAS (SEQ ID No. 1), FTLASSETG (SEQ ID No. 2), YDDQESVKS (SEQ ID No. 3) and FSKIASNTQ (SEQ ID No. 4). The peptides resemble MH |
| 5736317 |
Human T-cell line infected with HIV-2 which secretes a protein corresponding to native HIV-2 gp1 |
April 7, 1998 |
| A novel cell line chronically infected with HIV-2.sub.NIHZ virus secretes the precursor of the viral envelope proteins in extracellular medium. The cells grow well in serum-free medium which enables the concentration of the conditioned medium of the cells to be greatly increased (>100 |
| 5733556 |
Newcastle disease virus combination vaccine |
March 31, 1998 |
| The present invention provides a combination vaccine for use in the protection of poultry against ND comprising an expression system, such as a virus vector, expressing a NDV immunogenic protein, and a live NDV vaccine strain. It is demonstrated that such a combination vaccine affords |
| 5733523 |
Targeted delivery of a therapeutic entity using complementary oligonucleotides |
March 31, 1998 |
| The invention relates to novel labelled modified oligonucleotides useful for anti-sense therapy, a conjugate of a targeting moiety, such as an antibody and a modified oligonucleotide complementary to the labelled oligonucleotide, the combination of both being useful in therapy of viral |
| 5733492 |
Spinneret of gold and platinum-containing alloy |
March 31, 1998 |
| The invention relates to a spinneret of a very specific geometry which provides more strength compared with the commonly applied spinnerets, and to a spinneret made of a specific metal alloy which also provides a further high strength. In combination, a spinneret is resistant to spin |
| 5732479 |
Shoe with laminate embedded in spray-moulded compound sole |
March 31, 1998 |
| The invention relates to a waterproof shoe with a laminate positioned against the inner side of the outer layer, which includes at least one waterproof, water-vapour permeable interlining and a lining, where: the lower area of the laminate is essentially parallel to the underside of the |
| 5731451 |
Modified polyalkylauminoxane composition formed using reagent containing aluminum trialkyl silox |
March 24, 1998 |
| A process is disclosed for forming an aluminoxane composition comprising methylaluminoxane by mixing trimethylaluminum, or a mixture of trimethylaluminum and one or more other trihydrocarbylaluminum compounds, with an organoaluminum compound containing a trialkylsiloxide moiety and t |
| 5731101 |
Low temperature ionic liquids |
March 24, 1998 |
| A low temperature molten ionic liquid composition comprising a mixture of a metal halide and an alkyl-containing amine hydrohalide salt is described which is useful as a catalyst and a solvent in alkylation, arylation and polymerization reactions or as an electrolyte for batteries. The m |
| 5728859 |
Process for making monohydroxy-terminated phosphate compositions |
March 17, 1998 |
| The present invention is a process for forming monohydroxy-terminated aromatic oligomeric phosphates by the reaction of a diaryl halophosphate, such as diphenyl chlorophosphate, optionally in the presence of some monoaryl dihalophosphate, with an aromatic diol, such as resorcinol, to |
| 5728855 |
Modified polyalkylaluminoxane composition formed using reagent containing carbon-oxygen double b |
March 17, 1998 |
| The present invention relates to a process for forming a composition comprising oligomeric alkylaluminoxane, e.g., preferably methylaluminoxane, and moieties having the structure--OC(R).sub.3, where R is, for example, methyl, which comprises initially treating a composition comprisin |
| 5728569 |
Chicken anaemia agent vaccine |
March 17, 1998 |
| The present invention provides a live and inactivated Chicken Anaemia Agent vaccine capable of evoking an immune response in a vaccinated chicken. The CAA virus of the vaccine is attenuated by serial passages in embryonated eggs. |
| 5725949 |
Hollow-fiber bundle and mass-transfer and/or heat exchanger |
March 10, 1998 |
| A hollow-fiber bundle containing at least one core bundle, where the core bundle contains at least three hollow fibers which are arranged around a carrier thread, with at least one winding thread wound around them, where the cross-sectional form of the carrier thread varies along the len |
| 5721294 |
Air-drying aqueous polymer dispersions |
February 24, 1998 |
| The invention relates to an air-drying aqueous polymer dispersion based on a core/shell polymer having an alkyd resin in the core and an addition polymer grafted thereon, with 50-90 weight percent of the core/shell polymer being composed of alkyd resin and 50-10 weight percent being |
| 5721189 |
Treatment to improve the durability of a hydrodechlorination catalyst and catalyst |
February 24, 1998 |
| The durability of a supported noble metal hydrodechlorination catalyst can be improved by (1) treating the supported catalyst, which comprises support and catalytic noble metal, with a non-elemental halide compound, which is not a mineral acid (such as an alkali metal halide, an ammonium |
| 5720873 |
Method of floating calcium carbonate ore and flotation reagent therefor |
February 24, 1998 |
| The invention relates to a method of floating calcium carbonate ore containing silicates as impurities. Floatation is performed in the presence of a quaternary ammonium compound and an alkylene oxide adduct of an amine compound. The silicate being concentrated in the float. |
| 5719243 |
Use of peroxyacids as molecular weight regulators |
February 17, 1998 |
| A method of radically (co)polymerizing vinyl ester, vinyl halide, diene, acrylonitrile and .alpha.-olefin monomers, optionally with one or more ethylenically unsaturated monomers, with a polymerization initiator in the presence of an amount of at least one peroxyacid chain transfer agent |
| 5719128 |
Factor IIa inhibitors |
February 17, 1998 |
| Disclosed are compounds of the formula: X Y Z A P Q T which are highly potent, selective factor IIa inhibitors, X, when present, may be connected to T, may be H, CH.sub.3, an acyl group, or a general protective group. Y is D-DPA, D-Phe, D-Val, D-Ile, D-Nle, a phenylsulfonyl, Dansyle, or |
| 5718878 |
Mesoporous titania and process for its preparation |
February 17, 1998 |
| Essentially mesoporous titanium oxide materials, having an average pore diameter of no more than about 100 .ANG. (e.g., from about 20 .ANG. to about 50 .ANG.) and an average surface area of no less than about 300 m.sup.2 /gm, preferably no less than about 500 m.sup.2 /gm are disclosed |
| 5714101 |
Process of making polyketon yarn |
February 3, 1998 |
| The invention relates to polyketone yarns of which the maximum tangential modulus at an elongation of more than 0.2% is at least 10 N/tex which display both high strength and, if so desired, a high elongation at break. The quality number, which is measured on a single filament out of a b |
| 5712363 |
Oligomeric sterically hindered polyamine crosslinkers and coating compositions containing the sa |
January 27, 1998 |
| The present invention relates to coating compositions including a particular class of oligomeric sterically hindered polyamines as replacements for traditional blocked and unblocked polyamine crosslinkers. The use of these oligomeric sterically hindered polyamine crosslinkers results |
| 5712264 |
17-spiromethylene steroids |
January 27, 1998 |
| The invention relates to a steroid derivative which steroidal skeleton is bound at carbon atom 17 to a spiromethylene ring of the formula: ##STR1## wherein R.sub.a and R.sub.b are independently selected from the group consisting of hydrogen, methyl, and halogen; m is 1 or 2; and the |
| 5710144 |
C-11 substituted steroids for treating menopausal complaints |
January 20, 1998 |
| A C-11 substituted steroid and a method of use of a C-11 substituted steroid to treat osteoporosis. |
| 5709881 |
Tablet capsule or granule comprising desogestrel |
January 20, 1998 |
| The invention relates to a tablet, capsule, or granule for oral administration comprising desogestrel wherein desogestrel is mixed or dissolved in a solid selected from a lubricant free from organic solvents, and a waxy substance not being a lubricant. |
| 5708591 |
Method and apparatus for predicting the presence of congenital and acquired imbalances and thera |
January 13, 1998 |
| A method and apparatus are disclosed for predicting the presence of at least one congenital or acquired imbalance or therapeutic condition associated with thrombosis/hemostasis from at least one time-dependent measurement profile. At least one time-dependent measurement on an unknown |
| 5707953 |
Fluidized bed coated amidoperoxyacid bleach composition |
January 13, 1998 |
| A coated bleach composition for laundering which contains from 1-97 weight percent of an amidoperoxyacid, and 0-98 weight percent of a hydratable amidoperoxyacid compatible material, less than 2.0 weight percent of water, and a coating of 2-30 weight percent of a water-soluble salt a |
| 5705817 |
Apparatus for optical monitoring of a thread for irregularities |
January 6, 1998 |
| An apparatus for optical monitoring of at least one thread for irregularities, in particular for filament breaks in multifilament yarns, with a radiation source, a radiation detector, and a ray beam transmitted by the radiation source and received by the radiation detector and direct |
| 5705489 |
Bisconjugates comprising two saccharides and a spacer |
January 6, 1998 |
| The invention relates to a tuneable bisconjugate comprising two saccharides and a spacer, each saccharide being the same or different and comprising two to six monosaccharide units, at least one unit being uronic acid, characterized in that at least one of the saccharides per se has |
| 5703201 |
Catalyst for polymerization of polyketone formed by treatment with carbon monoxide and olefin |
December 30, 1997 |
| A process for the synthesis of a catalyst for the polymerization of carbon monoxide and at least one olefin which comprises treating a mixture of a compound of palladium, such as tetrakis(acetonitrile) palladium, and a Lewis acid anion, such as a fluoride of a metal selected from Group I |
| 5698736 |
High temperature, catalytic Friedel-Crafts synthesis of benzene phosphorus dichloride |
December 16, 1997 |
| Benzene phosphorus dichloride can be prepared by the reaction of benzene and phosphorus trichloride in the presence of a catalytically effective amount of a Friedel-Crafts catalyst, such as aluminum trichloride or ferric trichloride, at elevated temperature, such as from about 200.de |
| 5698203 |
European vaccine strains of the Porcine Reproductive Respiratory Syndrome virus (PRRSV) |
December 16, 1997 |
| The present invention is concerned with European strains of the Porcine Reproductive Respiratory Syndrome (PRRS) virus, which are attenuated, and show a characteristic reaction pattern with two monoclonal antibodies against wild-type PRRSV.The invention also relates to vaccines for the p |
| 5698007 |
Process for agglomerating particulate material |
December 16, 1997 |
| The present invention generally relates to a process of agglomerating particulate material in the presence of water which comprises mixing said particulate matreial with a binding effective amount of at least one water soluble polymer, and a binder enhancing effective amount of caustic, |
| 5693591 |
Activity promoting additives for rest-breaking agents |
December 2, 1997 |
| Activity promoting additives (alkoxylated amines and alkoxylated quaternary ammonium compounds) for rest-breaking agents are disclosed. Further, rest-breaking compositions comprising these additives and a rest-breaking agent are also disclosed. Finally, a process for breaking the rest of |
| 5693133 |
Asbestos free roof coatings |
December 2, 1997 |
| The present invention generally relates to an asbestos-free roof coating composition which comprises roof-coating asphalt cutback, an amine-based dispersion aid and various optional ingredients including fillers to obtain the desired bulk. The dispersion aid is an organic or inorganic |
| 5691455 |
Gonadotropins with non-native disulfide bridges |
November 25, 1997 |
| The present invention relates to gonadotropins consisting of an .alpha. and .beta. subunit, said gonadotropins comprising non-native disulfide bridges, preferably non-native intersubunit disulfide bridges. The gonadotropins according to the invention have improved stability. The pres |
| 5691029 |
Filament-reinforced nonwoven-fabric sheeting |
November 25, 1997 |
| Filament-reinforced nonwoven-fabric sheeting reinforced by sheets of parallel reinforcement yarns integrated into the nonwoven-fabric sheeting, whereby a binder is used to bind the filaments A forming the nonwoven fabric to filaments B of the reinforcement yarns at the crossing points of |
| 5690939 |
Recombinant vaccine against marek's disease |
November 25, 1997 |
| The invention is related to a nucleic acid sequence encoding a MD06 Marek's Disease Virus protein. Such a protein can be used for the immunization of poultry against MDV infection or disease. The nucleic acid sequence encoding the MD06 MDV protein can be applied for the preparation of th |
| 5690856 |
Solid diacyl organic peroxide dispersions |
November 25, 1997 |
| The present invention generally relates to solid diacyl organic peroxide formulations in liquid or paste form having improved thermal stability. The formulations generally comprise solid diacyl organic peroxide, a dispersing plasticizer having a solid organic peroxide solubility of from |
| 5688896 |
Non-linear optically active polycarbonate |
November 18, 1997 |
| The invention pertains to a non-linear optically active (NLO) side chain polycarbonate and to NLO active waveguides containing said polycarbonate. Waveguides containing this NLO polycarbonate have a low loss of signal. Polycarbonates based on bischloroformates of hexafluorobisphenol A, |
| 5686287 |
Marek's disease virus vaccine |
November 11, 1997 |
| The present invention is concerned with a new strain of Mareks Disease Virus and to a vaccine for the protection of poultry against Mareks Disease containing the novel strain. The invention also relates to bivalent or polyvalent vaccines comprising in addition other viruses of the Ma |
| 5686077 |
Methods of immunization of poultry with vaccines against chicken anemia agent (CAA) |
November 11, 1997 |
| The present invention provides a live and inactivated Chicken Anaemia Agent vaccine capable of evoking an immune response in a vaccinated chicken. The CAA virus of the vaccine is attenuated by serial passages in embryonated eggs. |
